A Phase 3 interventional study of Hutox Inj and Botox Inj in Glabellar Frown Lines, sponsored by Huons Co., Ltd.. Status unknown at 1 site in Korea, Republic of. Open to participants aged 20 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-04-12.
Sponsored by Huons Co., Ltd. (part of Huons Global) · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
A Phase Ⅲ Clinical Trial to Compare the Safety and Efficacy of Hutox versus Botox® in Subject with Moderate to Severe Glabellar Lines
Huons Co., Ltd. is the lead sponsor of 29 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Hutox Inj was given an injection to 5 glabellar lines each 4 U/0.1ml (Total 20 U/0.5ml, IM)
Biological: Hutox Inj
Botox Inj was given an injection to 5 glabellar lines each 4 U/0.1ml (Total 20 U/0.5ml, IM)
Biological: Botox Inj
Hutox Inj(Clostridium botulinum type A)
Botox Inj(Clostridium botulinum type A)
FWS(Facial Wrinkle Severity) Improvement at glabellar line
Change from Baseline of Glabellar Lines improvement rate(Frown)
Time frame: 4 Weeks
Started Nov 2017 (actual). Primary completion is estimated for Oct 2018, 11 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.